Novavax Inc (NASDAQ:NVAX) - Share price


Stock Report

Novavax Inc NVAX

Last Price
$171.74

Day Change
-8.93|-4.94%

As of 05/05/2021
19:59:58 EDT | USD
Minimum 15 Minutes Delay.

Last Close180.67
Day Range160.00 - 194.99
Mkt Cap12.72Bil
52-Wk Range16.92 - 331.68
Yield %-
ISINUS6700024010
Volume6,639,977
P/E-
P/S20.79
P/CF-232.36

Share Price

Financials
201820192020
More ...
Income Statement
Revenue34.2918.66475.60
Operating Income-173.92-129.60-416.72
Net Income-184.75-132.69-418.26
Basic EPS-10.00-5.51-7.27
Avg. Diluted Shares Outstanding182458
Balance Sheet
Current Assets119.2897.251,248.20
Non Current Assets88.7075.71334.28
Total Assets207.98172.961,582.48
Current Liabilities45.5425.80579.67
Total Liabilities375.91358.97955.27
Total Equity-167.94-186.02627.21
Cash Flow
Operating Cash Flow-184.83-136.62-42.54
Capital Expenditure-1.37-1.86-54.62
Free Cash Flow-186.20-138.48-97.16

In millions, except "Basic EPS". Currency is USD.

Company Profile

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

691
Key Stats
More ...
Price/Earning TTM-24.85
Price/Book21.34
Price/Sales TTM21.86
Rev Growth (3 year avg)148.01
EPS Growth (3 year avg)-
Operating Margin % TTM-87.62
Net Margin % TTM-87.94
ROE TTM-189.60
Debt/Equity0.58
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.